Our data provide the first evidence that cancer presence may significantly downregulate erythrocyte SphK1 activity (Figure 6A) and this significantly correlates with circulating S1P both in healthy individuals and in PCa patients (Supplementary Table S3). The gene discussed is MBTPS1; the disease is cancer.